Details for New Drug Application (NDA): 060593
✉ Email this page to a colleague
The generic ingredient in SEROMYCIN is cycloserine. There are seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the cycloserine profile page.
Summary for 060593
Tradename: | SEROMYCIN |
Applicant: | Cerovene Inc |
Ingredient: | cycloserine |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 060593
Suppliers and Packaging for NDA: 060593
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SEROMYCIN | cycloserine | CAPSULE;ORAL | 060593 | ANDA | Parsolex Gmp Center, Inc. | 13845-1200 | 13845-1200-3 | 40 CAPSULE in 1 BOTTLE (13845-1200-3) / 250 mg in 1 CAPSULE (13845-1200-1) |
SEROMYCIN | cycloserine | CAPSULE;ORAL | 060593 | ANDA | Parsolex Gmp Center, Inc. | 13845-1201 | 13845-1201-3 | 40 CAPSULE in 1 BOTTLE (13845-1201-3) / 250 mg in 1 CAPSULE (13845-1201-1) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 250MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Complete Access Available with Subscription